Search


Current filters:



Start a new search
Add filters:

Use filters to refine the search results.


Results 1-8 of 8 (Search time: 0.002 seconds).
  • previous
  • 1
  • next
Item hits:
PreviewIssue DateTitleAuthor(s)
2016The glucagon-like peptide 1 receptor agonist exenatide inhibits small intestinal motility, flow, transit, and absorption of glucose in healthy subjects and patients with type 2 diabetes: a randomized controlled trialThazhath, S.; Marathe, C.; Wu, T.; Chang, J.; Khoo, J.; Kuo, P.; Checklin, H.; Bound, M.; Rigda, R.; Crouch, B.; Jones, K.; Horowitz, M.; Rayner, C.
2013Effects of intraduodenal glutamine on incretin hormone and insulin release, the glycemic response to an intraduodenal glucose infusion, and antropyloroduodenal motility in health and type 2 diabetesChang, J.; Wu, T.; Greenfield, J.; Samocha-Bonet, D.; Horowitz, M.; Rayner, C.
2010Diabetic gastroparesis and its impact on glycemiaChang, J.; Rayner, C.; Jones, K.; Horowitz, M.
2013Prognosis of diabetic gastroparesisa 25-year evaluationChang, J.; Rayner, C.; Jones, K.; Horowitz, M.
2010Effect of the artificial sweetener, sucralose, on small intestinal glucose absorption in healthy human subjectsMa, J.; Chang, J.; Checklin, H.; Young, R.; Jones, K.; Horowitz, M.; Rayner, C.
2011Diabetic gastroparesis - Backwards and forwardsChang, J.; Rayner, C.; Jones, K.; Horowitz, M.
2012A 25-year longitudinal evaluation of gastric emptying in diabetesChang, J.; Russo, A.; Bound, M.; Rayner, C.; Jones, K.; Horowitz, M.
2013Response to comment on: Chang et al. A 25-Year longitudinal evaluation of gastric emptying in diabetes. Diabetes Care 2012;35:2594-2596Rayner, C.; Chang, J.; Jones, K.; Horowitz, M.